Picture of Admin User
New Online Course: Agomelatine in the Management of Depression
by Admin User - Friday, 27 February 2015, 11:58 AM
 

Professor Philip Boyce has developed a brand new online course on the latest pharmacological treatment for depression based on the circadian model.

Depression is a biopsychosocial illness. Studies of global burden of disease suggest that by 2020, major depressive disorder will represent the second leading cause of Disability-Adjusted Life Years lost globally, just behind ischaemic heart disease. There are a number of theoretical models to understand why people get depressed. Each of these models has its own mechanism and treatments. This course will focus on the circadian model and teach you how we can use agomelatine to manipulate patients' circadian rhythm in order to achieve better treatment outcomes from both patients' perspective and medical practitioners' perspective.

This course accepts enrolments throughout the year and does not have any prerequisite requirements.

On completion of the course, participants should be able to:

  • Describe the mechanism of the circadian model of depression.
  • Compare agomelatine to other antidepressants.
  • Demonstrate an understanding of patients' desired treatment outcomes for depression.
  • Explain how to measure and minimise patients' emotional blunting during treatment of depression.

Find more information or enrol via the link below:
http://cce.sydney.edu.au/course/amdc